AI-designed mRNA H5Nx vaccine achieves complete protection in animal challenge trials
EN
eFeedLink Newsdesk
A University of Cambridge and DIOSynVax candidate protected all challenged animals against antigenically distinct H5N1 clades, while stockpiled vaccines protected only about half.



